You just read:

Global Neuroendocrine Tumors (NET) Market Report 2017: Novartis Leads Industry Sponsors with the Highest Number of Clinical Trials for NETs, Followed by Ipsen and Pfizer

News provided by

Research and Markets

Feb 15, 2018, 09:45 ET